The BOLERO-2 trial: The addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

Julia A. Beaver, Ben H. Park

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The BOLERO-2 trial: The addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences